A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus

Abstract The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel β-sheets, β5 and β6. We have previously demonstrated that fragment 450–650 of the S protein (S450–650) is predominantly recognized by convalescent sera of SARS patients. The N-terminal 60 residues (450–510) of the S450–650 fragment covers the entire β6 strand of S-RBM. In the present study, we demonstrate that patient sera predominantly recognized 2 linear epitopes outside the β6 fragment, while the mouse antisera, induced by immunization of BALB/c mice with recombinant S450–650, mainly recognized the β6 strand-containing region. Unlike patient sera, however, the mouse antisera were unable to inhibit the infectivity of S protein-expressing (SARS-CoV-S) pseudovirus. Fusion protein between green fluorescence protein (GFP) and S450–650 (S450–650-GFP) was able to stain Vero E6 cells and deletion of the β6 fragment rendered the fusion product (S511–650-GFP) unable to do so. Similarly, recombinant S450–650, but not S511–650, was able to block the infection of Vero E6 cells by the SARS-CoV-S pseudovirus. Co-precipitation experiments confirmed that S450–650 was able to specifically bind with ACE2 molecules in lysate of Vero E6 cells. However, the ability of S450–510, either alone or in fusion with GFP, to bind with ACE2 was significantly poorer compared with S450–650. Our data suggest a possibility that, although the β6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein.

[1]  S. Harrison,et al.  Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.

[2]  Ruifu Yang,et al.  Antigenicity Analysis of Different Regions of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein , 2004, Clinical chemistry.

[3]  Wenhui Li,et al.  A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2* , 2004, Journal of Biological Chemistry.

[4]  Xiaolei Yin,et al.  Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. , 2004, The Journal of infectious diseases.

[5]  Mark Chappell,et al.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.

[6]  Shibo Jiang,et al.  Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine , 2004, Biochemical and Biophysical Research Communications.

[7]  C. Nardella,et al.  Mechanism of activation of human heparanase investigated by protein engineering. , 2004, Biochemistry.

[8]  Hongbo Hu,et al.  Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. , 2005, Journal of combinatorial chemistry.

[9]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[10]  Jincun Zhao,et al.  Prokaryotic expression, refolding, and purification of fragment 450–650 of the spike protein of SARS-coronavirus , 2004, Protein Expression and Purification.

[11]  Yanjun Zhou,et al.  Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus. , 2005, DNA and cell biology.

[12]  T. Ho,et al.  Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein , 2003, Biochemical and Biophysical Research Communications.

[13]  Shibo Jiang,et al.  Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies , 2005, The Journal of Immunology.

[14]  Weihong Jiang,et al.  Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential , 2005, FEBS Letters.

[15]  Huanming Yang,et al.  Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus , 2003, Clinical chemistry.

[16]  Yanjun Zhou,et al.  Identification of two antigenic epitopes on SARS-CoV spike protein , 2004, Biochemical and Biophysical Research Communications.

[17]  Xiaolei Yin,et al.  Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing Antibodies , 2004, Journal of Virology.

[18]  D. Dimitrov,et al.  Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain , 2004, Biochemical and Biophysical Research Communications.

[19]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[20]  C Kaether,et al.  Green fluorescent protein: applications in cell biology , 1996, FEBS letters.

[21]  Ying-hua Chen,et al.  Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody response. , 2005, Immunology letters.

[22]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[23]  Jincun Zhao,et al.  Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus , 2004, Journal of Clinical Virology.

[24]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[25]  Wenhui Li,et al.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Bernini,et al.  Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein , 2003, Biochemical and Biophysical Research Communications.